Czech Republic
France
Germany
Norway
Netherlands
Spain
Turkey
United KingdomUpdates
SUB-TYPE: CLASS 2 RECALL
Class 2 recall-Lercanidipine HCl 20mg Tablets
We have received a Class 2 Recall from Recordati Industria Chimica e Farmaceutica S.p.A. on Lercanidipine HCl 20mg Tablets.
DMRC Ref: 35334038
Reason: “Recordati Pharmaceuticals Limited has informed the MHRA of an error in the strength of the product printed on some of the faces (sides) of the product carton. The error is limited to one batch of Lercanidipine HCl 20mg Tablets. The packs are incorrectly labelled as 10mg on some sides of the product carton when they are 20mg tablets.”
Please can you ensure that your stores quarantine the product listed below.
| PIP CODE | PRODUCT DESCRIPTION | Supplier | BATCH NUMBER |
|---|---|---|---|
| 1152404 | Lercanidipine HCl 20mg Tablet | RECORDATI PHARMACEUTICALS LTD | MD4L07 |
| 8449779 | |||
| 1149590 | |||
| 1154111 |
Further Information
For all medical information enquiries and information on this product, please email medinfo@recordati.co.uk, or telephone +353 (0)87 6245669. For stock control enquiries please email customerservice@recordati.com, or telephone 01491 576 336.
Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification (17/04/2025), cannot be reimbursed by way of a credit.
SUB-TYPE:
Early May 2025 bank holiday opening hours
To help keep our customers informed of changes to our service, we have published our Early May 2025 bank holiday opening hours for pharmacy and retail customers.
Early May 2025 bank holiday opening hours
Early May 2025 bank holiday opening hours (for Channel Islands and Isle of Man)
SUB-TYPE: CLASS 2 RECALL
Class 2 recall-Synalar 30g & 60g gel
It has been identified that the batches of Synalar Gel 30g and 60g listed in this notification contain a residual solvent (benzene) at a level exceeding the ICH limit of 2ppm. Reig Jofre UK are recalling the batches as a precautionary measure. This recall is at the pharmacy and wholesaler level.
MHRA ref:DMRC-35165402
PIP CODE | PRODUCT DESCRIPTION | BATCH NUMBER |
0278010 | SYNALAR GEL (30g) | L303A L304A L401A L403A L404A |
3279882 | SYNALAR GEL (60g) | L301A L402A |
Further Information
For medical information enquiries please contact Reig Jofre UK Medical Information on 0330 1359 434 or by email MedInfoUK@reigjofre.com.
Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 4 CAUTION IN USE
Class 4 caution in use-Renacet 465 & 950 mg tablets
RenaCare NephroMed GmbH has informed the MHRA of the presence of an undeclared excipient in the coating of the tablets. This excipient is Macrogol 6000, which has always been included in Renacet Tablets but has been omitted from the list of excipients in error.
Pip code | Product description | Supplier | Batch Numbers |
3594199 | RENACET 475 MG | STANNINGLEY PHARMA LTD | See attached |
3594207 | RENACET 950MG | STANNINGLEY PHARMA LTD | See attached |
This is a caution in use only we are not accepting stock returns
Further Information
For medical information enquiries please telephone 01159 124 253 or email medinfo@stanningleypharma.co.uk
For stock control enquiries telephone 01159 124 253 or email medinfo@stanningleypharma.co.uk
SUB-TYPE: CLASS 3 RECALL
Class 3 recall-Urospir 50mg/5ml solution
Rosemont Pharmaceuticals Limited is recalling a single batch of Urospir 50mg/5ml Oral Solution (spironolactone) as a precautionary measure. The recall is due to errors in some of the dose calculation in millilitres being stated incorrectly in the SmPC and PIL.
MHRA ref: DMRC-35150350
Pip code | Product description | Supplier | Batch Numbers |
1277201 | UROSPIR 50MG/5ML ORAL SF SOL | ROSEMONT PHARMA | 1014870 |
Further Information
For all medical information enquiries and information on this product, please contact pharmacovigilance@rosemontpharma.com, or telephone 0113 244 1400. For stock control enquiries please contact customerservices@rosemontpharma.com, or telephone 0113 244 1999.
Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 2 RECALL
Class 2 recall-PI Utrogestan 200mg capsules
Uni Health Distribution Ltd has informed the MHRA of a typographical error on the approved carton overlabel for certain batches of Utrogestan Vaginal 200 mg Capsules. The carton label references ‘micrograms’ where it should actually state ‘milligrams’.
MHRA ref:DMRC-35159465
PIP CODE | PRODUCT DESCRIPTION | BATCH NUMBER |
Alliance do not stock | PI UTROGESTAN 200MG CAPS | See above link |
Further Information
For further information and all enquiries please contact info@uhdltd.co.uk
Please return all affected stock to your original supplier for credit. Unfortunately, we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.
Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.
SUB-TYPE: CLASS 4 CAUTION IN USE
Class 4 caution in use-PI sirdupla 25/250mcg
Cross Healthcare Limited have informed the MHRA that there is a printing defect on the outer labels for the Sirdupla 25 microgram/250 microgram per metered dose pressurised inhalation, suspension, batch 77518.
MHRA Drug alert date: 31st March 2025
Pip code | Product description | Supplier | Batch Numbers |
8414948 | PI SIRDUPLA 25/250MCG 120D | Cross Healthcare Limited | 77518 |
This is a caution in use only we are not accepting stock returns
Further Information
For further information please email gary@crosshealthcare.co.uk or telephone 01786 817707.
SUB-TYPE:
Easter Bank Holiday Opening Hours 2025
To help keep our customers informed of changes to our service, we have published our Easter 2025 bank holiday opening hours for pharmacy and retail customers.
Easter Bank Holiday Opening Hours 2025
Channel Islands and Isle of Man Easter Bank Holiday Opening Hours 2025
Cavendish Easter BH opening hours 2025
SUB-TYPE:
Alliance Healthcare Introduces OptiTote to Drive Efficiencies for Pharmacists
Alliance Healthcare is today announcing the launch of OptiTote, a semi automated repeat dispensing solution, designed to improve efficiency and accuracy in pharmacy operations.
The technology will enable pharmacists to partially automate repeat prescription dispensing, simplifying the dispensing operation and freeing up valuable time. This will enable pharmacists to devote more time to growing their business, including upskilling staff and patient care.
As Pharmacies face increasing pressure to optimise workflows, expand services, and reduce costs, OptiTote’s partial automation removes the need for manual unpacking and shelf picking, allowing pharmacy teams to collate patient orders more accurately using advanced barcode scanning technology. Furthermore, OptiTote's 'just in time' stock fulfilment allows pharmacies to maintain lower inventory levels, thereby reducing the capital tied up in stock.
How does it work?
Managed entirely by in-house dispensing teams, this patient-specific tote system integrates seamlessly with Alliance Healthcare’s ordering systems, offering a more streamlined approach to repeat prescriptions.
Unlike traditional repeat prescription management, OptiTote enables pharmacies to maintain full control over prescriptions while accelerating the dispensing process.
OptiTote is ordered via the OptiTote software, the order is encrypted to protect patient data and is sent through to the Alliance Healthcare service centre, where it is assembled ready for dispatch the following morning. The OptiTote is delivered with the pharmacy’s standard Alliance Healthcare order.
Paula Sutherland, Sales Director at Alliance Healthcare said: "Now more than ever, pharmacies need innovative solutions to simplify processes and enable them to focus more on patient care. As pharmacies adapt to evolving healthcare demands, OptiTote provides a practical solution that simplifies and speeds up repeat prescription dispensing, giving pharmacists more time to spend training their teams, supporting patients or running their business.”
Dr Jackie Lewis - Pharmacist Director of Lewis Pharmacy in Exmouth, Devon said: “As a business owner and superintendent I have more time to devote to governance of the pharmacy and to developing private services and developing my skills as an IP Pathfinder which can be up to 6 half day sessions per week. Through Optitote we have more available staff time which enables us to run technician service clinics 3 mornings a week.”
The standard OptiTote system is available at no cost and is integrated into existing PMR workstations. The OptiTote team at Alliance Healthcare provide a detailed bespoke training plan for each pharmacy to ensure that key pharmacy team members are fully trained and are confident in using the product. The training is conducted in a live environment within the pharmacy with the Alliance OptiTote product technician on hand to support and guide.
Visit our webpage to find out more information including how to enquire about OptiTote.
Pharmacies can also reach out to their Alliance Healthcare account manager if you’d like to sign up to OptiTote. If eligible, our dedicated team will then work with the pharmacy with a mutual date to install the kit and then train and support the pharmacy team.
SUB-TYPE:
Alliance Healthcare UK announces changes to its network
Alliance Healthcare UK today announced that it was continuing the transformation of its network by commencing development of a new, multipurpose Central Logistics Centre (CLC) in Birmingham that will become its largest facility and most advanced in Europe.
Set to open in spring 2026, the CLC will create more than 200 jobs and incorporate 95% pick automation alongside an advanced radio frequency identification solution unique to Alliance Healthcare UK. The CLC comprises 300,000 square feet, increasing the company’s total UK warehouse space by 25%.
In creating this capacity, the CLC will absorb a small proportion of production from a handful of neighbouring service centres (SCs). Additionally, Alliance Healthcare UK proposes to close both Hinckley and Nottingham SCs in 2026 and transition slow moving medical lines from South Normanton SC to the CLC.
Representing a significant investment by parent company Cencora, the CLC location is driven by Alliance Healthcare UK’s current service centre estate, proximity to national driving routes and the anticipated needs of the company’s future customer base.
For more information about this announcement, please email pressoffice@alliance-healthcare.co.uk.